Adeleh Taghi Khani | Senior Scientist II
Quest Diagnostics
Adeleh Taghi Khani is an accomplished scientist with over five years of experience in Immunology and immunogenicity, specializing in therapeutic areas like oncology and autoimmunity. Currently a Scientist II at Quest Diagnostics, she excels in developing immunogenicity assays and strategies, and previously held the position of Scientist III at AbbVie. Adeleh holds a PhD in Immunology and has over 20 publications, multiple awards, and patents in cancer immunotherapy. Her strengths lie in cross-functional collaboration, problem-solving, and project execution.
Appearances:
Festival of Biologics Day 2 @ 17:10
Regulatory-Compliant Strategies for Timely and Cost-Effective Immunogenicity Risk Assessment and Mitigation
- Immunophenotyping of Cells in Response to Biologics in alignment with guidelines.
- Evaluation of Innate and Adaptive Immune responses.
- Implementation of Validated Tools, Automation, and Broad Platforms for immunogenicity assessment, adhering to FDA-recommended methodologies
last published: 25/Mar/25 09:15 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events